GT20029 China Phase II Trial For AGA Reached Primary Endpoint ...Middle East

PR Newswire - News
SUZHOU, China, April 21, 2024 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the China phase II clinical trial (the "Phase II Clinical...

Hence then, the article about gt20029 china phase ii trial for aga reached primary endpoint was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GT20029 China Phase II Trial For AGA Reached Primary Endpoint )

Apple Storegoogle play

Last updated :

Also on site :